Do you want to read an article? Please log in or register.
TETRIS - Prospective study to observe clinical outcomes of triple therapy in COPD patients: up to 12 months interim analysis
COPD
Related content
COPD
Clinical Stability under FF/UMEC/VI Triple Inhaled Therapy: A 12-Month Real Life Retrospective Observational Study
Respir Med
Maniscalco M, Candia C, Pennisi F, Pennisi A, De Simone G, Ambrosino P
doi: 10.1016/j.rmed.2026.108633
RECOMMENDED
COPDPneumonia
Comparing Major COPD Triple Therapy Trials Using a Structured Multi-Criteria Decision Analysis: A Deep Dive into Patient Populations and Outcomes
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Respir Med
Cazzola M, Maniscalco M, Patella V, Calzetta L, Matera MG, Rogliani P
doi: 10.1016/j.rmed.2025.108292
RECOMMENDED
COPD
Real-World Efficacy of BDP/FF/G Fixed Triple Inhalation Powder (NEXThaler) Therapy in the Treatment of Moderate to Severe COPD patients (RESPONSE Study)
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
Respir Med
Dulai V, Keglevich A, Sánta B, Abonyi-Tóth Z, Horváth I
doi: 10.1016/j.rmed.2025.108498
RECOMMENDED
COPDLung Cancer
Impact of Triple Inhaler Therapy on COPD Patients with Non-Small Cell Lung Cancer After Radical Surgery: A Single-Centre Retrospective Analysis
★ 1
Recommended by
Dr Martin Frey, Faculty Member
J Clin Med
Bertuccio FR, D'Agnano V, Cordoni S, Tafa M, Novy C, Baio N, Mucaj K, Bortolotto C, Melloni G, Bianco A, Corsico AG, Perrotta F, Stella GM
doi: 10.3390/jcm14010249
COPD
Comparison of the Risk of Pneumonia Between Fluticasone Furoate/Umeclidinium/Vilanterol and Multiple-Inhaler Triple Therapy in Patients with COPD Using Health Insurance Claims Data: Final Analysis of Post-Marketing Database Surveillance in Japan
J Clin Med
Akiyama S, Oda K, Mizohata H, Sasakura N, Hashimoto K, Maruoka H
doi: 10.3390/jcm14134697
Lung Cancer
Immunotherapy Improves Clinical Outcome in Kirsten Rat Sarcoma Virus-Mutated Patients with Unresectable Non-Small Cell Lung Cancer Stage III: A Subcohort Analysis of the Austrian Radio-Oncological Lung Cancer Study Association Registry (ALLSTAR)
J Clin Med
Ruznic E, Klebermass M, Zellinger B, Langer B, Grambozov B, Purevdorj A, Karner J, Gruber G, Stana M, Minasch D, Kirchhammer K, Steffal C, Stranzl H, Moosbrugger R, Feurstein P, Dieckmann K, Zehentmayr F, ALLSTAR Group
doi: 10.3390/jcm14030945
RECOMMENDED
ARDS
Different Duration of Prone Positioning Treatment for Patients with Acute Respiratory Distress Syndrome in Intensive Care Unit Patients: A Prospective Randomized Clinical Study
★ 1
Recommended by
Dr Martin Frey, Faculty Member
J Clin Med
Hsu CW, Liu SM, Yang CY, Sun SF, Kuo SH, Chu KA
doi: 10.3390/jcm14207261
Lung Cancer
Real-World Treatment Patterns and Clinical Outcomes in Patients With Extensive-Stage Small Cell Lung Cancer Treated With First-Line Platinum-Based Chemotherapy and ≥ 2 Subsequent Lines of Therapy in the United States
Adv Ther
Sankar K, Unni S, Eberl M, Le H, Herrmann T, Gorsh B, Tang M, Coerts F, Ahmed S
doi: 10.1007/s12325-025-03408-z
COPD
Step up to triple therapy versus switch to dual bronchodilator therapy in patients with COPD on an inhaled corticosteroid/long-acting β(2)-agonist: post-hoc analyses of KRONOS
Respir Res
Singh D, Bafadhel M, Arya N, Marshall J, Parikh H, Kisielewicz D, Movitz C, Bowen K, Patel M
doi: 10.1186/s12931-025-03234-5